Skip to content

ALZAMEND NEURO, INC.: 10-Q filed 2024-12-11

What ALZAMEND NEURO, INC. reported in its quarterly report filed 2024-12-11 (fiscal Q2 2024): 32 published measures, 96 facts as tagged in accession 0001214659-24-020264.

This filing

Form
10-Q (quarterly report)
Filed
2024-12-11
Fiscal period
fiscal Q2 2024
Accession
0001214659-24-020264 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALZAMEND NEURO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-10-315,007,718USD
At 2024-04-30631,588USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-10-311,254,750USD
At 2024-04-303,225,773USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-10-313,752,968USD
At 2024-04-30-2,594,185USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-10-314,093,073USD
At 2024-04-30376,048USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-1,415,214USD92
2024-05-01 to 2024-10-31-2,389,625USD184
2023-08-01 to 2023-10-31-2,906,033USD92
2023-05-01 to 2023-10-31-6,433,799USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-05-01 to 2024-10-31-4,455,843USD184
2023-05-01 to 2023-10-31-4,811,624USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-05-01 to 2024-10-318,262,868USD184
2023-05-01 to 2023-10-3118,087USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-05-01 to 2024-10-31-90,000USD184
2023-05-01 to 2023-10-31-147,243USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-10-31-56,410,033USD
At 2024-04-30-54,020,408USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-08-01 to 2024-10-313,531,702shares92
2024-05-01 to 2024-10-312,154,761shares184
2023-08-01 to 2023-10-31656,378shares92
2023-05-01 to 2023-10-31656,323shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-08-01 to 2024-10-313,531,702shares92
2024-05-01 to 2024-10-312,154,761shares184
2023-08-01 to 2023-10-31656,378shares92
2023-05-01 to 2023-10-31656,323shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-0.4USD/shares92
2024-05-01 to 2024-10-31-1.11USD/shares184
2023-08-01 to 2023-10-31-4.43USD/shares92
2023-05-01 to 2023-10-31-9.8USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-0.4USD/shares92
2024-05-01 to 2024-10-31-1.11USD/shares184
2023-08-01 to 2023-10-31-4.43USD/shares92
2023-05-01 to 2023-10-31-9.8USD/shares184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-10-31240,976USD
At 2024-04-30176,346USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-05-01 to 2024-10-31162,554USD184
2023-05-01 to 2023-10-31687,716USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-1,358,068USD92
2024-05-01 to 2024-10-31-2,320,473USD184
2023-08-01 to 2023-10-31-2,901,722USD92
2023-05-01 to 2023-10-31-6,427,652USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-10-314,766,742USD
At 2024-04-30455,242USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-08-01 to 2024-10-313,495USD92
2024-05-01 to 2024-10-3115,501USD184
2023-08-01 to 2023-10-314,311USD92
2023-05-01 to 2023-10-316,147USD184

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-10-311,254,750USD
At 2024-04-302,925,059USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-08-01 to 2024-10-311,358,068USD92
2024-05-01 to 2024-10-312,320,473USD184
2023-08-01 to 2023-10-312,901,722USD92
2023-05-01 to 2023-10-316,427,652USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-08-01 to 2024-10-31311,088USD92
2024-05-01 to 2024-10-31517,659USD184
2023-08-01 to 2023-10-311,996,783USD92
2023-05-01 to 2023-10-314,362,920USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-10-315,231,254shares
At 2024-04-30687,999shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-10-314,093,073USD
At 2024-04-30376,048USD
At 2023-10-31200,079USD
At 2023-04-305,140,859USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-10-3160,162,478USD
At 2024-04-3051,426,154USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-10-313,752,968USD
At 2024-07-31-1,212,319USD
At 2024-04-30-2,594,185USD
At 2023-10-31-2,682,493USD
At 2023-07-31-112,883USD
At 2023-04-303,045,503USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-10-31673,669USD
At 2024-04-3079,194USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-1,361,563USD92
2024-05-01 to 2024-10-31-2,335,974USD184
2023-08-01 to 2023-10-31-2,906,033USD92
2023-05-01 to 2023-10-31-6,433,799USD184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-1,415,214USD92
2024-05-01 to 2024-10-31-2,389,625USD184
2023-08-01 to 2023-10-31-2,906,033USD92
2023-05-01 to 2023-10-31-6,433,799USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-08-01 to 2024-10-311,046,980USD92
2024-05-01 to 2024-10-311,802,814USD184
2023-08-01 to 2023-10-31904,939USD92
2023-05-01 to 2023-10-312,064,732USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-05-01 to 2024-10-3125,370USD184
2023-05-01 to 2023-10-3125,370USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-08-01 to 2024-10-31-3,495USD92
2024-05-01 to 2024-10-31-15,501USD184
2023-08-01 to 2023-10-31-4,311USD92
2023-05-01 to 2023-10-31-6,147USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-05-01 to 2024-10-311,174,224USD184
2023-05-01 to 2023-10-3118,087USD184

Inspect the source

Entity
ALZAMEND NEURO, INC. / CIK 0001677077
Captured
2026-09-19T11:20:15.101Z
SEC response SHA-256
e091f00311cdd2d05377e177e0a2cf10b9fbab20ba26d0f97f3815f0b0cf6790

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001677077.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))